StockData
Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc. (RYTM) stock

RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)

Close on Nov 17, 2026Market cap $8.03BP/E –Yield –

Rhythm Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Rhythm Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$105.35M. For fiscal 2025 it was -$115.68M. The highest annual figure on record is -$6.98M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$115.68M–
FY2024Dec 31, 2024-$113.88M–
FY2023Dec 31, 2023-$136.16M–
FY2022Dec 31, 2022-$173.43M–
FY2021Dec 31, 2021-$146.00M–
FY2020Dec 31, 2020-$121.98M–
FY2019Dec 31, 2019-$122.75M–
FY2018Dec 31, 2018-$62.06M–
FY2017Dec 31, 2017-$29.46M–
FY2016Dec 31, 2016-$23.22M–
FY2015Dec 31, 2015-$6.98M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.15M–
Q1 FY2026Mar 31, 2026-$44.19M–
Q4 FY2025Dec 31, 2025-$25.39M–
Q3 FY2025Sep 30, 2025-$26.62M–
Q2 FY2025Jun 30, 2025-$23.31M–
Q1 FY2025Mar 31, 2025-$40.35M–
Q4 FY2024Dec 31, 2024-$18.85M–
Q3 FY2024Sep 30, 2024-$25.22M–
Q2 FY2024Jun 30, 2024-$29.08M–
Q1 FY2024Mar 31, 2024-$40.74M–
Q4 FY2023Dec 31, 2023-$29.38M–
Q3 FY2023Sep 30, 2023-$29.25M–
Q2 FY2023Jun 30, 2023-$41.09M–
Q1 FY2023Mar 31, 2023-$36.43M–
Q4 FY2022Dec 31, 2022-$34.00M–
Q3 FY2022Sep 30, 2022-$46.99M–
Q2 FY2022Jun 30, 2022-$38.81M–
Q1 FY2022Mar 31, 2022-$53.63M–
Q4 FY2021Dec 31, 2021-$40.47M–
Q3 FY2021Sep 30, 2021-$40.16M–
Q2 FY2021Jun 30, 2021-$31.84M–
Q1 FY2021Mar 31, 2021-$33.53M–
Q4 FY2020Dec 31, 2020-$29.12M–
Q3 FY2020Sep 30, 2020-$27.03M–
Q2 FY2020Jun 30, 2020-$29.73M–
Q1 FY2020Mar 31, 2020-$36.10M–
Q4 FY2019Dec 31, 2019-$32.22M–
Q3 FY2019Sep 30, 2019-$33.61M–
Q2 FY2019Jun 30, 2019-$25.55M–
Q1 FY2019Mar 31, 2019-$31.38M–
Q4 FY2018Dec 31, 2018-$20.98M–
Q3 FY2018Sep 30, 2018-$16.94M–
Q2 FY2018Jun 30, 2018-$12.48M–
Q1 FY2018Mar 31, 2018-$11.65M–
Q4 FY2017Dec 31, 2017-$7.89M–
Q3 FY2017Sep 30, 2017-$8.42M–
Q2 FY2017Jun 30, 2017-$6.14M–
Q1 FY2017Mar 31, 2017-$7.02M–
Q4 FY2016Dec 31, 2016-$6.18M–

More Rhythm Pharmaceuticals figures

See a number that looks wrong?